Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. (Q52519428)

2 May 2018

title

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection. (English)

1 reference

2 May 2018

main subject

Leishmania amazonensis

object named as

Leishmania amazonensis

1 reference

9

Flavell RA

1 reference

2 May 2018

Iqbal S Grewal

3

object named as

Grewal IS

1 reference

2 May 2018

author name string

Soong L

1

1 reference

2 May 2018

Xu JC

2

1 reference

2 May 2018

Kima P

4

1 reference

2 May 2018

Sun J

5

1 reference

2 May 2018

Longley BJ Jr

6

1 reference

2 May 2018

Ruddle NH

7

1 reference

2 May 2018

McMahon-Pratt D

8

1 reference

2 May 2018

language of work or name

English

0 references

publication date

1 March 1996

1 reference

2 May 2018

published in

Immunity

1 reference

2 May 2018

volume

4

1 reference

2 May 2018

issue

3

1 reference

2 May 2018

page(s)

263-273

1 reference

2 May 2018

Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Alterations of the immune response associated with chronic experimental leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

The CD40 antigen and its ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Late metastatic Leishmaniasis in the mouse. A model for mucocutaneous disease

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Recombinant interleukin 12 cures mice infected with Leishmania major

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Interleukin 12 is produced in vivo during endotoxemia and stimulates synthesis of gamma interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

The Role of CD40 and its Ligand in the Regulation of the Immune Response

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Immunodeficiency due to a faulty interaction between T cells and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Interleukin 12 is effective treatment for an established systemic intracellular infection: experimental visceral leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

The role of CD40L (gp39)/CD40 in T/B cell interaction and primary immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Serum from infected mice suppresses macrophage-mediated immunity in Mycobacterium lepraemurium infection: a model for impaired macrophage immunity in human leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Constructing polycompetitor cDNAs for quantitative PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

CD40 ligand-transduced co-stimulation of T cells in the development of helper function

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Infection with Leishmania major induces interleukin-12 production in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Role of the CD40-CD40 ligand interaction in CD4+ T cell contact-dependent activation of monocyte interleukin-1 synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Altered immune responses in mice lacking inducible nitric oxide synthase

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Rapid induction of a novel costimulatory activity on B cells by CD40 ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

Mice deficient for the CD40 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS1074-7613%2800%2980434-3

7 January 2021

10.1016/S1074-7613(00)80434-3

Identifiers

DOI

1 reference

2 May 2018

PubMed ID

8624816

1 reference

2 May 2018